RecruitingNot ApplicableNCT06219694

Laser Acupuncture for Chronic Migraine

Enhancing Chronic Migraine Preventive Therapy: Laser Acupuncture as an Add-On Treatment for Patients With Unsatisfactory Pharmacological Effect, a Pilot Randomized Controlled Trial


Sponsor

Taichung Veterans General Hospital

Enrollment

60 participants

Start Date

Jan 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

A single-blind randomized controlled trial was conducted from October 2024 to May 2025. Chronic migraine patients were randomly assigned in a 1:1 ratio to receive either Laser acupuncture or sham treatment. The co-primary outcomes were changes in monthly migraine days (MMD) and acute headache medications usage days per month from baseline, and Hospital Anxiety and Depression Scale (HADS), and Beck's Depression Inventory(BDI) evaluation. Evaluations were taken at baseline and each follow-up point. After \>6 months follow up as washing out time, the sham group received complementary laser acupuncture treatment and follow up for another 3 months, compared the Headache related parameters (onset, duration, pain scale, current medication for headache, menstrual cycle).


Eligibility

Min Age: 20 Years

Inclusion Criteria3

  • patients aged above 20 years old and had CM managed pharmacologically, including preventive and/or acute migraine medications, and in addition, those who had refused preventive agent despite recommendation of the neurologist;
  • patients who had unsatisfactory effect of current pharmacological treatments, defined as they self-reported
  • patients who had a minimum of one-year history of migraine with or without aura.

Exclusion Criteria4

  • patients who had received another LA therapy or traditional acupuncture at baseline
  • migraine onset after the age of 50
  • cognitive or psychological impairment interfering with the participant's ability to receive LA protocol and describe symptoms
  • patients with missing data at baseline or during the follow-up period.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELaser Acupuncture

Laser stimulation energy of 4.5 J for 30 seconds at each of the following acupoints: bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3)

DEVICESham

Sham treatment with no laser output, stimulate the same acupoints as laser acupuncture group as follows: 30 seconds at bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3) After \> 6 months followed up, the sham group received truely Laser stimulation energy of 4.5 J for 30 seconds at each of the following acupoints: bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3), and followed up for another 3 months.


Locations(1)

Taichung Veterans General Hospital

Taichung, Xitun District, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06219694


Related Trials